전립선 특이 항원(PSA) 검사 시장 규모, 점유율 및 성장 분석 : 검사 유형별, 기술별, 용도별, 최종사용자별, 검체 유형별, 제품 유형, 지역별 - 업계 예측(2026-2033년)

Global Prostate Specific Antigen Test Market size was valued at USD 5.1 Billion in 2024 and is poised to grow from USD 5.46 Billion in 2025 to USD 9.46 Billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026-2033).

The global market for prostate specific antigen (PSA) testing encompasses diagnostic kits, automated analyzers, and ancillary services aimed at prostate cancer screening and monitoring. The rising need for early detection, fueled by prostate cancer being the second most prevalent cancer in men, emphasizes the critical nature of these tests. Recent advancements have led to high sensitivity immunoassays and point-of-care devices, enhancing access and reducing turnaround times, particularly in emerging markets like India, Brazil, and China. Additionally, the integration of precision medicine has prompted a demand for high throughput assays, driving laboratory automation investments. This evolution, alongside reimbursement reforms favoring early detection, enables firms to capitalize on advancements demonstrating clinical value and cost-effectiveness in PSA testing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Prostate Specific Antigen Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Prostate Specific Antigen Test Market Segments Analysis

Global prostate specific antigen test market is segmented by test type, technology, application, end user, sample type, product type and region. Based on test type, the market is segmented into Total PSA Test, Free PSA Test, Complexed PSA Test and PSA Velocity & PSA Density Tests. Based on technology, the market is segmented into Immunoassays, Chemiluminescence Immunoassays (CLIA), Enzyme-Linked Immunosorbent Assays (ELISA) and Point-of-Care Testing. Based on application, the market is segmented into Prostate Cancer Screening, Prostate Cancer Monitoring, Benign Prostatic Hyperplasia (BPH) Assessment and Post-Treatment Surveillance. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Specialty Urology Clinics and Ambulatory Care Centers. Based on sample type, the market is segmented into Blood Serum and Plasma. Based on product type, the market is segmented into Test Kits & Reagents, Instruments & Analyzers and Consumables & Accessories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Prostate Specific Antigen Test Market

The increasing awareness among the public and healthcare professionals about the advantages of early detection of prostate cancer is leading to a rise in the number of men opting for regular PSA testing. This trend is consequently boosting the demand for diagnostic kits and associated services. Healthcare providers are incorporating PSA screening into routine preventive health measures, which enhances patient engagement and contributes to consistent market growth. Additionally, this growing awareness fuels educational efforts that encourage the widespread adoption of testing among various demographics, thereby supporting the ongoing expansion of the global prostate-specific antigen test market.

Restraints in the Global Prostate Specific Antigen Test Market

The Global Prostate Specific Antigen (PSA) Test market faces significant challenges due to the tendency of PSA testing to yield false positive results. This issue generates uncertainty among patients and healthcare providers, often resulting in unnecessary invasive procedures and increased anxiety levels. Such outcomes can undermine confidence in the screening process, leading some clinicians to favor more conservative testing approaches. This caution can deter the routine ordering of tests, particularly among low-risk populations, ultimately hindering market growth. Moreover, concerns regarding overdiagnosis contribute to public discussions that may affect policy decisions, potentially limiting the wider use of PSA assays in national screening initiatives.

Market Trends of the Global Prostate Specific Antigen Test Market

The Global Prostate Specific Antigen (PSA) Test market is witnessing a significant trend towards personalized screening protocols, fueled by advancements in genomics and enhanced risk stratification techniques. Healthcare providers are increasingly combining PSA test outcomes with genetic markers, family histories, and lifestyle factors to create individualized screening plans that optimize detection accuracy. This tailored approach not only aims to improve early diagnosis of prostate conditions but also minimizes the necessity for invasive biopsies, thereby enhancing patient safety and comfort. Additionally, the use of decision-support tools that integrate diverse data points is facilitating more patient-centered care, allowing clinicians to confidently navigate varying risk profiles and long-term management strategies.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Disease Epidemiology

Global Prostate Specific Antigen Test Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Total PSA Test
• Free PSA Test
• Complexed PSA Test
• PSA Velocity & PSA Density Tests

Global Prostate Specific Antigen Test Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunoassays
• Chemiluminescence Immunoassays (CLIA)
• Enzyme-Linked Immunosorbent Assays (ELISA)
• Point-of-Care Testing

Global Prostate Specific Antigen Test Market Size by Application & CAGR (2026-2033)

• Market Overview
• Prostate Cancer Screening
• Prostate Cancer Monitoring
• Benign Prostatic Hyperplasia (BPH) Assessment
• Post-Treatment Surveillance

Global Prostate Specific Antigen Test Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Specialty Urology Clinics
• Ambulatory Care Centers

Global Prostate Specific Antigen Test Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Blood Serum
• Plasma

Global Prostate Specific Antigen Test Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Test Kits & Reagents
• Instruments & Analyzers
• Consumables & Accessories

Global Prostate Specific Antigen Test Market Size & CAGR (2026-2033)

• North America (Test Type, Technology, Application, End User, Sample Type, Product Type)
  • US
  • Canada
• Europe (Test Type, Technology, Application, End User, Sample Type, Product Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Technology, Application, End User, Sample Type, Product Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Technology, Application, End User, Sample Type, Product Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Technology, Application, End User, Sample Type, Product Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wondfo Biotech Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trivitron Healthcare Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujirebio Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Snibe Diagnostic Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getein Biotech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autobio Diagnostics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioVendor Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations